Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04477499 · ClinicalTrials.gov registry record
Parallel Mapping for Ventricular Tachycardia
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 44
- Enrollment target
NCT04477499: Completed study, sponsored by The Cleveland Clinic.
NCT04477499 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04477499 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
Catheter ablation in patients with ventricular tachycardia using a new mapping algorithm called, parallel mapping, that is aimed to increase the specificity of mapping and the outcome of ablation.
Primary Outcome
Number of VT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2022-12-30 |
What the finished NCT04477499 record still lists
NCT04477499 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04477499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04477499 about?
NCT04477499 is a clinical study titled "Parallel Mapping for Ventricular Tachycardia". Catheter ablation in patients with ventricular tachycardia using a new mapping algorithm called, parallel mapping, that is aimed to increase the specificity of mapping and the outcome of ablation.
What is the current status of trial NCT04477499?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2020-07-15. Estimated completion is 2022-12-30.
Who is sponsoring clinical trial NCT04477499?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI